尽管有部分内部采购和研发重点,但FMC的股票在收益下降,负利和降低价格目标的情况下下跌. FMC's stock dropped amid declining earnings, negative margins, and reduced price targets, despite some insider buying and R&D focus.

2026年初,FMC的股票面临着分析师的混合情绪,过去一个月没有看评级,其12个月平均价格目标大幅下降至17.20美元,从30.40美元. In early 2026, FMC's stock faced mixed analyst sentiment, with no bullish ratings in the past month and a sharp drop in its average 12-month price target to $17.20 from $30.40. 尽管第三季度财报低于预期，但收入同比下降了49.1%，公司报告净利润率为负，盈利能力指标下降。 Despite a Q3 earnings beat, revenue fell 49.1% year-over-year, and the company reported negative net margins and declining profitability metrics. 花旗集团将其价格目标提高到16.00美元,但保持中立的评级,而分析师则总体上保持“坚持”共识。 Citigroup raised its price target to $16.00 but kept a neutral rating, while analysts overall maintain a "Hold" consensus. 尽管内部采购和强大的研发重点仍然是关注点,但FMC的债务与股权比率和不良财务业绩引发了担忧. FMC's debt-to-equity ratio and poor financial performance raise concerns, though insider purchases and a strong R&D focus remain points of interest.